Fortrea Holdings (FTRE) Change in Cash (2022 - 2026)
Fortrea Holdings (FTRE) reported Change in Cash of -$27.1 million for Q1 2026, down 60.36% on a YoY basis from -$68.4 million in Q1 2025, and down 162.59% quarter-over-quarter from $43.3 million in Q4 2025.
Fortrea Holdings (FTRE) Change in Cash (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Change in Cash for 5 years, with the latest figure at -$27.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 60.36% year-over-year to -$27.1 million; the trailing twelve-month figure through Mar 2026 stood at $45.9 million (up 421.59% YoY), and the FY2025 full-year result was $56.1 million, up 466.67% from the prior year.
- Change in Cash for Q1 2026 stood at -$27.1 million, down from $43.3 million in the prior quarter.
- The five-year high for Change in Cash was $50.1 million in Q3 2025, with the low at -$27.1 million in Q1 2026.
- Historically, Change in Cash has averaged $3.5 million across 5 years, with a median of $2.9 million in 2022.
- The largest YoY upside for Change in Cash was 459.14% in 2024 against a maximum downside of 309.8% in 2024.
- Fortrea Holdings' Change in Cash stood at $2.9 million in 2022, then jumped by 65.52% to $4.8 million in 2023, then soared by 175.0% to $13.2 million in 2024, then surged by 228.03% to $43.3 million in 2025, then tumbled by 162.59% to -$27.1 million in 2026.
- The last three Change in Cash figures came in at -$27.1 million (Q1 2026), $43.3 million (Q4 2025), and $50.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -27.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.10 Mn |
| Dec 31, 2025 | 43.30 Mn |
| Sep 30, 2025 | 50.10 Mn |
| Jun 30, 2025 | -20.40 Mn |
| Mar 31, 2025 | -16.90 Mn |
| Dec 31, 2024 | 13.20 Mn |
| Sep 30, 2024 | -20.90 Mn |
| Jun 30, 2024 | 33.40 Mn |
| Mar 31, 2024 | -15.80 Mn |
| Dec 31, 2023 | 4.80 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -9.30 Mn |
| Mar 31, 2023 | 7.80 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Sep 30, 2022 | 12.00 Mn |